ArticleTranslational oncology2018

Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience.

Fangzheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.